Balancing IP protection with the need for accessible cancer treatments requires innovative solutions. One approach is the use of compulsory licenses, which allow a government to permit the production of a patented product without the consent of the patent owner under certain conditions. Another method is the tiered pricing strategy, where drug prices are adjusted based on the economic status of a country. Additionally, fostering public-private partnerships can help balance innovation with accessibility.
